Cite
Considerations for Human ADME Strategy and Design Paradigm Shift(s) – An Industry White Paper.
MLA
Young, Graeme C., et al. “Considerations for Human ADME Strategy and Design Paradigm Shift(s) – An Industry White Paper.” Clinical Pharmacology & Therapeutics, vol. 113, no. 4, Apr. 2023, pp. 775–81. EBSCOhost, https://doi.org/10.1002/cpt.2691.
APA
Young, G. C., Spracklin, D. K., James, A. D., Hvenegaard, M. G., Scarfe, G., Wagner, D. S., Georgi, K., Schieferstein, H., Bjornsdottir, I., van Groen, B., Romeo, A. A., Cassidy, K. C., Da, violante, G., Bister, B., Blech, S., Lyer, R., Schulz, S. I., Cuyckens, F., & Moliner, P. (2023). Considerations for Human ADME Strategy and Design Paradigm Shift(s) – An Industry White Paper. Clinical Pharmacology & Therapeutics, 113(4), 775–781. https://doi.org/10.1002/cpt.2691
Chicago
Young, Graeme C., Douglas K. Spracklin, Alexander D. James, Mette G. Hvenegaard, Graeme Scarfe, David S. Wagner, Katrin Georgi, et al. 2023. “Considerations for Human ADME Strategy and Design Paradigm Shift(s) – An Industry White Paper.” Clinical Pharmacology & Therapeutics 113 (4): 775–81. doi:10.1002/cpt.2691.